查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945466

2026年全球快速側向流動免疫檢測（LFIA）檢測市場報告

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於側向流動免疫檢測（LFIA）的快速檢測市場規模持續擴大，預計將以2.0%的複合年成長率成長，從2025年的71.7億美元成長到2026年的73.1億美元。過去幾年的成長可歸因於快速感染疾病篩檢的擴展、懷孕和不孕症檢測的日益普及、照護現場診斷的發展、低成本快速檢測的廣泛應用以及公共衛生篩檢措施的增加。

基於側向流動免疫檢測（LFIAT）的快速檢測市場規模預計將在未來幾年穩步成長，到2030年將達到86.7億美元，複合年成長率（CAGR）為4.3%。成長要素：對基於快速免疫檢測的檢測需求不斷成長、家用LFIAT試劑盒的普及率不斷提高、多重檢測方法的應用範圍不斷擴大、傳染病檢查的應用範圍不斷擴大以及對方便用戶使用型檢測設計日益重視。

慢性病盛行率的上升預計將推動基於側向流動免疫檢測(LFIA) 的快速檢測市場成長。慢性病（也稱為非傳染性疾病：NCDs）是指長期、持續的健康問題，通常會伴隨人的一生。基於 LFIA 的快速檢測能夠實現早期發現、就地檢驗、快速出結果、持續監測，並降低與慢性病管理相關的醫療保健成本。這些檢測因其快速且便捷的檢測結果而備受推崇，使醫護人員和患者能夠及時做出有關治療和生活方式調整的決策。例如，根據英國政府機構國家醫療服務體系（NHS）發布的數據，截至2024年6月，在全科醫生處登記的3,615,330名患者在2023年被診斷患有非糖尿病性高血糖或糖尿病前期，比2022年的3,065,825例增加了18%。因此，慢性病盛行率的上升正在推動基於液相界面分析（LFIA）的快速檢測市場的擴張。

市場參與企業正致力於研發先進的診斷技術，以提高效率和患者照護。例如，Integrated Health Solutions 正在整合醫療服務、技術和數據，以增強跨醫療平台的工作流程和協作。 2024 年 6 月，總部位於瑞士的製藥公司羅氏 (F. Hoffmann-La Roche AG) 發布了其 Cobas Pro 整合解決方案的分析單元。該系統使用樣本供應單元時每小時可處理多達 1000 個檢體，使用離子選擇性電極 (ISE) 分析時每小時可處理 900 個測試，而使用 Cobas C 503 臨床化學單元時每小時可處理 1000 個測試，從而提高檢查室效率和患者照護水平。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球側向流動免疫檢測（LFIA）快速檢測市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧與自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 對基於快速免疫檢測的檢測方法的需求不斷成長
    • 擴大家用LFIa套件的推廣
    • 多重檢測分析方法的廣泛應用
    • 擴大傳染病檢查應用範圍
    • 越來越重視使用者友善的測試設計

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 居家照護用戶
  • 公共衛生機構
  • 製藥和生物技術公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球側向流動免疫檢測（LFIA）快速檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球側向層析免疫檢測（LFIA）快速檢測市場規模、對比及成長率分析
  • 全球側向流動免疫檢測（LFIA）快速檢測市場表現：規模與成長，2020-2025年
  • 全球側向流動免疫檢測(LFIA) 快速檢測市場預測：規模與成長，2025-2030 年，2035 年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 透過技術
  • 競爭性檢測、夾心檢測和多重檢測
  • 透過使用
  • 感染疾病、懷孕和不孕症治療、毒理學、心臟標記和膽固醇檢測以及其他用途
  • 最終用戶
  • 醫院/診所、診斷檢查室、居家醫療和其他終端用戶
  • 按類型細分：競爭性偵測
  • 直接競爭性檢測，間接競爭性檢測
  • 按類型細分：夾心法檢測
  • 一步法夾心法檢測，兩步驟法夾心法檢測
  • 按類型細分：多重偵測分析
  • 多分析物檢測，同時檢測多種標靶

第10章 區域與國家分析

  • 全球快速側向層析免疫檢測(LFIA) 檢測市場：區域分析、績效及預測（2020-2025 年、2025-2030 年預測、2035 年預測）
  • 全球快速側向層析免疫檢測(LFIA) 檢測市場：國家/地區、性能和預測，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 側向流動免疫檢測（LFIA）快速偵測市場：競爭格局與市場佔有率，2024年
  • 快速側向層析免疫檢測(LFIA) 檢測市場：公司評估矩陣
  • 快速側向層析免疫檢測（LFIA）檢測市場：公司概況
    • Abbott Laboratories
    • F. Hoffmann-La Roche
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Danaher Corporation

第37章：其他領先和創新企業

  • Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience（R）Immunoassay Kits, FyoniBio/Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 快速側向流動免疫檢測(LFIA) 檢測市場 2030：提供新機會的國家
  • 快速側向流動免疫檢測(LFIA) 檢測市場 2030 年展望：新興細分市場機會
  • 快速側向流動免疫檢測(LFIA) 檢測市場 2030 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MLFIL02_G26Q1

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

Tariffs are influencing the LFIA based rapid test market by increasing costs of imported antibodies, membranes, nanoparticles, reader components, and packaging materials. Healthcare systems and diagnostic manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on large-scale test production. These tariffs are increasing unit costs and affecting affordability. At the same time, they are driving domestic manufacturing, local sourcing of assay components, and innovation in cost-efficient rapid test formats.

The lateral flow immunoassay (lfia) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (lfia) based rapid test market statistics, including lateral flow immunoassay (lfia) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (lfia) based rapid test market share, detailed lateral flow immunoassay (lfia) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (lfia) based rapid test industry. This lateral flow immunoassay (lfia) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (lfia) based rapid test market size has grown steadily in recent years. It will grow from $7.17 billion in 2025 to $7.31 billion in 2026 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to expansion of rapid infectious disease screening, increasing adoption of pregnancy and fertility tests, growth of point-of-care diagnostics, availability of low-cost rapid tests, rising public health screening initiatives.

The lateral flow immunoassay (lfia) based rapid test market size is expected to see steady growth in the next few years. It will grow to $8.67 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing investments in decentralized diagnostics, expansion of self-testing applications, growing demand for rapid cardiac and toxicology tests, rising integration with digital health platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing demand for rapid immunoassay-based testing, rising adoption of home-use lfia kits, growing use of multiplex detection assays, expansion of infectious disease testing applications, enhanced focus on user-friendly test design.

The rising prevalence of chronic diseases is expected to drive growth in the lateral flow immunoassay (LFIA) based rapid test market. Chronic diseases, also referred to as non-communicable diseases (NCDs), are long-term health conditions that persist over extended periods, often throughout a person's lifetime. LFIA-based rapid tests facilitate early detection, point-of-care testing, rapid results, ongoing monitoring, and reduced healthcare costs associated with chronic disease management. These tests are valued for providing quick and accessible results, allowing healthcare professionals and patients to make timely decisions regarding treatment and lifestyle adjustments. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. As a result, the growing prevalence of chronic diseases is supporting the expansion of the LFIA-based rapid test market.

Companies in the market are focusing on advanced diagnostic technologies to improve efficiency and patient care. Integrated Health Solutions, for instance, connect healthcare services, technologies, and data to enhance workflow and collaboration across healthcare platforms. In June 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, launched analytical units for its Cobas Pro integrated solutions. The system can process up to 1,000 samples per hour using its sample supply unit and perform up to 900 tests per hour for ion-selective electrode (ISE) analysis and 1,000 tests per hour on the Cobas C 503 unit for clinical chemistry, streamlining laboratory operations and improving patient care.

In August 2023, Danaher Corporation, a US-based medical products company, acquired Abcam plc for $5.7 billion. This acquisition aligns with Danaher's strategy to expand its life sciences business and support clients in addressing major healthcare challenges. Abcam plc, a UK-based biotechnology company, specializes in the manufacture of LFIA-based rapid tests, and the acquisition is expected to enhance value for shareholders while delivering improved outcomes for employees and clients.

Major companies operating in the lateral flow immunoassay (lfia) based rapid test market are Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Hologic Inc., LTEK Co. Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, 3a Diagnostics, Roche Holding AG, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lateral flow immunoassay (lfia) based rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lateral flow immunoassay (lfia) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technique: Competitive Assay; Sandwich Assay; Multiplex Detection Assay
  • 2) By Application: Infectious Disease; Pregnancy And Fertility; Toxicology; Cardiac Marker And Cholesterol Testing; Other Applications
  • 3) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End Users
  • Subsegments:
  • 1) By Competitive Assay: Direct Competitive Assays; Indirect Competitive Assays
  • 2) By Sandwich Assay: Single-step Sandwich Assays; Two-step Sandwich Assays
  • 3) By Multiplex Detection Assay: Multi-analyte Assays; Simultaneous Detection Of Various Targets
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Hologic Inc.; LTEK Co. Ltd.; JOYSBIO Biotechnology; Jiangsu Medomics Medical Technologies; Diagnocure; Ubio Biotechnology Systems; Elabscience(R) Immunoassay Kits; FyoniBio / Glycotope GmbH; Atomo Diagnostics Limited; INDICAL Bioscience; Lionex Gmbh; BIOMED Labordiagnostik GmbH; EKF Diagnostics; Launch Diagnostics; Diagnostic Instruments Ltd; Qiagen N.V.; Merck KGaA; 3a Diagnostics; Roche Holding AG; Biomaxima; SensDx; Vitrosens Biotechnology; Bioeasy Biotechnology; Fujirebio; Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; CTK Biotech
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
    • 4.1.5 Industry 4.0 And Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Demand For Rapid Immunoassay-Based Testing
    • 4.2.2 Rising Adoption Of Home-Use Lfia Kits
    • 4.2.3 Growing Use Of Multiplex Detection Assays
    • 4.2.4 Expansion Of Infectious Disease Testing Applications
    • 4.2.5 Enhanced Focus On User-Friendly Test Design

5. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Home Care Users
  • 5.4 Public Health Organizations
  • 5.5 Pharmaceutical And Biotechnology Companies

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 9.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Competitive Assay, Sandwich Assay, Multiplex Detection Assay
  • 9.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
  • 9.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
  • 9.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Competitive Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Competitive Assays, Indirect Competitive Assays
  • 9.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Sandwich Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-step Sandwich Assays, Two-step Sandwich Assays
  • 9.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Multiplex Detection Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Multi-analyte Assays, Simultaneous Detection Of Various Targets

10. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 10.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. Taiwan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. South East Asia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 30.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 31.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 32.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 33.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 34.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regulatory and Investment Landscape

36. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 36.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH

38. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

40. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market High Potential Countries, Segments and Strategies

  • 40.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer